Hook & thesis
Celestica has quietly become a key assembler for hyperscaler AI infrastructure - building custom racks and integrating advanced compute. If the new high-performance AI chips (market chatter refers to this wave as the 'Jalapeño' ramps) begin broad deployments, Celestica stands to pick up outsized revenue and margin tailwinds given its manufacturing footprint and existing hyperscaler relationships. We are upgrading our stance to Buy and laying out a mid-term swing trade to capture this potential re-rating.
The company's recent operational beat - $4.05 billion of revenue in Q1 2026 (+53% year-over-year) and an uplift to $19 billion in full-year revenue guidance - shows management is already benefiting from an acceleration in AI infrastructure work. That combination of revenue momentum, positive free cash flow and conservative leverage makes Celestica a practical way to play the next wave of hyperscaler capex if the 'Jalapeño' ramps scale as expected.
Business overview - why the market should care
Celestica is a global supply chain and electronics manufacturing partner split across Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS). The latter is the obvious lever for AI infrastructure demand - Celestica assembles servers, storage and custom racks where advanced chips are mounted and cooled. Hyperscalers increasingly outsource complex assembly so they can scale capex quickly; that is Celestica's addressable market.
Why 'Jalapeño' specifically matters: next-generation AI chips often require specialized mechanical integration, power delivery and thermal solutions - capabilities Celestica offers at scale. When a hyperscaler signs on for a new chip family, component orders are sequential and concentrated: PCB assembly, module integration, rack-level customization, and final test/validation. Celestica sits in the middle of that chain. If the 'Jalapeño' ramps proceed, Celestica's ATS/CCS businesses should see both revenue growth and a favorable mix shift to higher-margin integration work.
Support from the numbers
| Metric | Value |
|---|---|
| Q1 2026 revenue | $4.05B (up 53% YoY) |
| 2026 full-year revenue guidance | $19.0B |
| Market capitalization | $38.7B |
| Enterprise value | $39.03B |
| Free cash flow (trailing figure) | $518.7M |
| PE (trailing / snapshot) | ~35x |
| EV/EBITDA | ~25x |
| ROE | ~45% |
Those numbers tell a coherent story: revenue momentum is real (Q1 +53% YoY) and management raised FY guidance to $19 billion. At a $38.7 billion market cap, the company is trading around a 2.0x forward price-to-sales multiple when you use the $19 billion guidance (market cap / guidance revenue = 38.7 / 19 = 2.04). A ~35x trailing earnings multiple looks rich in isolation, but the multiple compresses if growth continues and margins improve as higher-value assembly work scales.
Valuation framing
At $38.7 billion market cap and an EV of $39.03 billion, Celestica is no longer a deep-value play; the market assigns a premium to its role in advanced hardware assembly. EV/EBITDA of ~25x and free cash flow of $518.7M imply the market expects sustained, healthy growth and stable margins. That expectation is reasonable if hyperscaler capex remains elevated and Celestica continues to capture design-win share for new racks tied to high-performance chips.
Relative to historical ranges, the stock has traded as high as $474 (52-week high) and as low as $183.66. Today's level around $316 sits between those extremes and reflects both optimism about AI demand and concern about short-term volatility - investors punished the stock in late April despite a beat and guide-up. That pullback can be read two ways: as a funding rotation or as an opportunity to buy into a secular trend with confirmed revenue acceleration.
Catalysts to drive the trade
- Hyperscaler chip ramps - public and private next-gen AI chip programs (market referred to as 'Jalapeño') initiating volume production and procurement cycles.
- Quarterly beats and raised guidance - the Q1 print and the $19B guide set a precedent; another beat would drive re-rating if margins move up.
- Large hyperscaler contracts or public partnerships - any disclosed multi-quarter assembly deals would materially derisk the thesis.
- Industry-wide capex announcements - macro commitments by Anthropic, Google or Meta to expand TPU/AI deployments strengthen the sector tailwind.
Trade plan (actionable)
We are upgrading to Buy and proposing a mid-term (45 trading days) swing trade to capture initial re-rating if 'Jalapeño' ramps accelerate shipments.
| Action | Price |
|---|---|
| Entry | $317.00 |
| Stop loss | $285.00 |
| Target (mid-term - 45 trading days) | $380.00 |
Why these levels? Entry at $317 is near the current trading level and allows participation without chasing an intraday spike. The $285 stop caps downside to roughly -10% from entry and sits below key technical support formed after the April sell-off. A $380 target is a realistic re-rate if Celestica confirms continued revenue strength or announces a meaningful hyperscaler contract - it represents ~20% upside from entry and still below the 52-week high, allowing room for additional upside on follow-through.
Timeframe rationale
We pick a mid-term horizon - 45 trading days - because ramp announcements and initial production milestones for new chips typically create a visible revenue cadence and investor interest within several weeks. That horizon allows enough time for order flows to show up in guidance or for the market to re-price the stock as contracts become visible.
Risks and counterarguments
- Demand concentration and timing risk - Hyperscaler decisions are lumpy. A delayed or smaller-than-expected ramp for 'Jalapeño' chips would push revenue into a later period and could compress the multiple.
- Execution risk - Complex integration and qualification cycles for new chip platforms can be longer and more expensive than planned; missed milestones reduce margin upside.
- Valuation vulnerability - At ~35x trailing earnings and EV/EBITDA ~25x, the stock is expensive relative to cyclical EMS peers if growth cools; multiple contraction is a tangible downside.
- Macro / capex pullback - If hyperscalers pause or re-prioritize capex, the entire AI hardware supply chain, including Celestica, could see softening orders.
- Competition & pricing pressure - Other EMS firms or in-house builds by hyperscalers could limit Celestica's ability to convert wins into higher margins.
Counterargument
One reasonable counterpoint is that recent market behavior shows investor skepticism: the stock experienced sharp intraday declines around late April even after a strong quarter and raised guidance. That suggests investors may be pricing in tougher-than-expected competition, execution risk, or a near-term reallocation of capex. On a valuation basis, paying ~35x trailing EPS requires continued high growth and margin expansion - not a sure thing. A wait-for-more-proof stance is valid: watching for a confirmed design win or better-than-expected Q2 guidance would materially lower risk.
What would change my mind
I would turn cautious if Celestica reports sequentially negative guidance revisions or increasing R&D/qualification costs tied to new chip platforms that materially depress margins. A formal announcement that a major hyperscaler is internalizing a larger share of rack integration would also diminish the investment case. Conversely, public disclosure of multi-year assembly contracts tied to new AI chips, sizable margin expansion, or sustained free cash flow growth would reinforce the bullish thesis and justify a higher target.
Conclusion
Celestica is a practical, actionable play on the next wave of AI infrastructure if the so-called 'Jalapeño' chip ramps scale. The company has demonstrable revenue momentum - Q1 revenue of $4.05B (+53% YoY) and a $19B guide - and the balance sheet and cash generation to support execution. Valuation is rich enough to demand delivery, but not extreme when framed against guidance-driven price-to-sales. We upgrade to Buy and recommend a mid-term swing trade: enter at $317.00, stop at $285.00, target $380.00 over 45 trading days. Monitor contract announcements and quarterly guidance closely; they are the real catalysts that will decide whether Celestica is merely complicit with AI growth or a primary beneficiary.
Trade plan reminder: mid-term (45 trading days). Entry: $317.00. Stop: $285.00. Target: $380.00.